Changes in sows productivity indicators when using complex hepatoprotective drug

To prevent toxic hepatosis in sows, a hepatoprotective drug was used under the working name "Karnivit". The composition of the drug includes carnitine, vitamin E, zinc complexonate, sodium citrate. To assess the preventive effectiveness, control, basic and experimental groups of pregnant and lactating sows were formed. Sows of the base group received methionine and sodium citrate together with compound feed, vitamin E - in the form of injections. Sows of the experimental group with the diet received the drug "Karnivit" in prophylactic dosages. The preparations were used in pregnant sows of the base and experimental groups from the 60th day of gestation to farrowing. In suckling sows of the base and experimental groups, the experience (the use of drugs) lasted from the third day after farrowing until the piglets were weaned. When using the drug "Karnivit" during the period of gestation of sows of the experimental group, the number of "technological" piglets in the offspring increased (due to a decrease in stillborn and physiologically immature). Also, the sows of the experimental group had a higher live weight of piglets: 9.3 % higher than in the control group, and 9.2 % higher than in the base group. When using the drug "Karnivit" in the lactation period, an increase in the safety of piglets in the experimental group of sows was found to be 3.5 % compared to the control group and 2.6 % compared to the baseline. The average weight of a piglet at weaning and the average daily gain in live weight of piglets were also higher in the experimental group of sows. Conclusions are drawn about the preventive effectiveness of the drug "Karnivit" due to an increase in the weight of newborn piglets, a decrease in stillbirth among them, an increase in safety and weight gain during the suction period.